Results 71 to 80 of about 24,314 (291)

Traceability on RSA-based Partially Signature with Low Computation

open access: yes, 2012
[[abstract]]In this article, we show that the Chien et al.’s partially blind signature scheme based on RSA public cryptosystem could not meet the untraceability property of a blind ...
黃明祥;Hwang, Min-Shiang;Cheng-Chi Lee;Yan-Chi Lai
core  

Blind Signature Scheme over Braid Groups [PDF]

open access: yes, 2008
A blind signature scheme is a cryptographic protocol for obtaining a signature from a signer such that the signer\u27s view of the protocol cannot be linked to the resulting message signature pair.
Girraj Kumar Verma
core  

Lattice-based (Partially) Blind Signature without Restart [PDF]

open access: yes, 2020
We present in this paper a blind signature and its partially blind variant based on lattices assumptions. Blind signature is a cornerstone in privacy-oriented cryptography and we propose the first lattice based scheme without restart.
Guillaume Kaim   +5 more
core  

Impact of Plasma p‐tau181 on Cognition, Motor Phenotypes, and Disease Course in ALS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Phosphorylated tau181 (p‐tau181), an Alzheimer's disease biomarker, was recently evaluated in amyotrophic lateral sclerosis (ALS). We investigated plasma p‐tau181 in 202 ALS/ALS‐FTD patients and 94 healthy controls, assessing cognitive performance, motor function, and longitudinal dynamics.
Elisabeth Kasper   +25 more
wiley   +1 more source

A new lattice-based partially blind signature with more complete proof

open access: yesJournal of Information and Intelligence
Partially blind signatures are introduced on the basis of blind signatures, which not only retain the advantages of blind signatures, but also solve the contradiction between anonymity and controllability in blind signatures.
Peiyu Li, Juntao Gao, Xuelian Li
doaj   +1 more source

Supersingular Isogeny-Based Designated Verifier Blind Signature [PDF]

open access: yes, 2019
Recently, Srinath and Chandrasekaran have proposed an undeniable blind signature scheme (UBSS) from supersingular isogeny to provide signer’s control in a quantum-resistant blind signature.
GINI, Agnese   +5 more
core  

Comprehensive Characterization of 98 Chinese Cases of Genetic Creutzfeldt‐Jakob Disease With T188K Mutation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize the demographic, clinical, and laboratory features of the Chinese patients of genetic Creutzfeldt‐Jakob disease with T188K variant (T188K‐gCJD), the most common subtype of genetic prion diseases (gPrDs) in China. Methods In this nationwide retrospective study, data from 98 genetically confirmed T188K‐gCJD patients ...
Chun‐Jie Li   +11 more
wiley   +1 more source

The Systematization of Blind Signature Schemes

open access: yesБезопасность информационных технологий, 2015
The paper presents the systematization of existing schemes of blind signatures. The analysis of different types of digital signatures and blind signatures was done, mathematical background of blind signature schemes was examined.
Anna Vasilievna Epishkina   +1 more
doaj  

Pairing Free Identity-Based Blind Signature Scheme with Message Recovery

open access: yesCryptography, 2018
With the rapid development of modern technology, personal privacy has become a critical concern in many applications. Various digitalized applications such as online voting systems and the electronic cash systems need authenticity and anonymity.
Salome James   +2 more
doaj   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy